KOKON: A Germany-Wide Collaborative Research Project to Identify Needs, Provide Information, Foster Communication and Support Decision-Making about Complementary and Alternative Medicine in Oncology

Background: The German Cancer Aid set up a priority research programme with the intention to generate high-quality information based on evidence and to make this information easily accessible for health-care professionals and advisors, researchers, patients, and the general public. Summary: The Kompetenznetz Komplementärmedizin in der Onkologie (KOKON) received 2 funding periods within this programme. During the first funding period, KOKON assessed patients’ and health-care professionals’ informational needs, developed a consulting manual for physicians, developed an education programme for self-help groups, set up a knowledge database, and developed a pilot information website for patients. Funding period 2 continues with work that allows cancer patients and health-care professionals to make informed decisions about complementary and alternative medicine (CAM). For this aim, KOKON evaluates training programmes for physicians (oncology physicians, paediatric oncologists, and general practitioners) and for self-help groups. All training programmes integrate results from an analysis of the ethical, psychological, and medical challenges of CAM in the medical encounter, and the knowledge database is being extended with issues related to CAM for supportive and palliative care. Key Message: A Germany-wide collaborative research project to identify needs, provide information, foster communication, and support decision-making about CAM in oncology is being set up.

[1]  Janine Ziemann,et al.  Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment , 2019, European Journal of Clinical Pharmacology.

[2]  C. Witt,et al.  Evaluation of a blended-learning training concept to train oncology physicians to advise their patients about complementary and integrative medicine (KOKON-KTO): study protocol for a prospective, multi-center, cluster-randomized trial , 2019, Trials.

[3]  M. Horneber,et al.  Addressing Unmet Information Needs: Results of a Clinician-Led Consultation Service About Complementary and Alternative Medicine for Cancer Patients and Their Relatives , 2018, Integrative cancer therapies.

[4]  C. Guethlin,et al.  Information and Training Needs Regarding Complementary and Alternative Medicine: A Cross-sectional Study of Cancer Care Providers in Germany , 2016, Integrative cancer therapies.

[5]  C. Lampert,et al.  Kompetenznetz Komplementärmedizin in der Onkologie (KOKON) , 2017, Im Focus Onkologie.

[6]  C. Witt,et al.  A consultation training program for physicians for communication about complementary medicine with breast cancer patients: a prospective, multi-center, cluster-randomized, mixed-method pilot study , 2016, BMC Cancer.

[7]  J. Weis,et al.  Beweggründe von Krebspatienten für und gegen die Inanspruchnahme der Misteltherapie , 2016, Complementary Medicine Research.

[8]  Güthlin Corina,et al.  Oncologists’ experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis , 2016, Supportive Care in Cancer.

[9]  S. Wahl How to Find an Alternative : A Typology of Cancer Patients ’ Information Behavior With Regard to Complementary and Alternative Medicine , 2016 .

[10]  J. Weis,et al.  Bedeutung komplementärmedizinischer Verfahren bei Patienten mit Prostatakarzinom , 2014, Der Urologe.

[11]  Jane T Williams Credible Complementary and Alternative Medicine Websites , 2013, Journal of the advanced practitioner in oncology.

[12]  A. Hasenburg,et al.  Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study. , 2012, European journal of cancer.

[13]  B. Oh,et al.  Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. , 2012, The oncologist.

[14]  M. Zwahlen,et al.  How Many Cancer Patients Use Complementary and Alternative Medicine , 2012, Integrative cancer therapies.

[15]  J. Armer,et al.  Complementary and alternative medicine use among women with breast cancer: a systematic review. , 2010, Clinical journal of oncology nursing.

[16]  P. Butow,et al.  Discussing Complementary Therapy Use With Early-Stage Breast Cancer Patients: Exploring the Communication Gap , 2010, Integrative cancer therapies.

[17]  M. Jefford,et al.  Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. , 2010, Patient education and counseling.

[18]  Y. K. Chan,et al.  Prevalence of Complementary Medicine Use in Pediatric Cancer: A Systematic Review , 2010, Pediatrics.

[19]  C. Spix,et al.  Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany. , 2008, European journal of cancer.

[20]  D. Roter,et al.  The Roter interaction analysis system (RIAS): utility and flexibility for analysis of medical interactions. , 2002, Patient education and counseling.

[21]  A Furnham,et al.  Why do patients turn to complementary medicine? An empirical study. , 1996, The British journal of clinical psychology.